A Systematic Review of the Safety of Lisdexamfetamine Dimesylate

BACKGROUND: Here we review the safety and tolerability profile of lisdexamfetamine dimesylate (LDX), the first long-acting prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD). METHODS: A PubMed search was conducted for English-language articles published up to 16 S...

Descripción completa

Detalles Bibliográficos
Autores principales: Coghill, David R., Caballero, Beatriz, Sorooshian, Shaw, Civil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057639/
https://www.ncbi.nlm.nih.gov/pubmed/24788672
http://dx.doi.org/10.1007/s40263-014-0166-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057639/
https://www.ncbi.nlm.nih.gov/pubmed/24788672
http://dx.doi.org/10.1007/s40263-014-0166-2

Ejemplares similares